组织陈列-产品详情

home > TISSUE ARRAYS > Multiple organ > UBD812

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

81

CASES:

27

Core Diameter(mm):

2

Thickness(µm):

5

Row number:

9

Column number:

9

Tissue Array Type:

FFPE

Species:

Human

UBD812

$275.00

Description: Bladder cancer tissue array with bladder tissue, including pathology grade, TNM and clinical stage, 27 cases/81 cores

Details: Bladder carcinoma tissue microarray with bladder tissue, containing 15 cases of bladder carcinoma (10 with matched cancer adjacent tissue), 12 squamous cell carcinoma of cervix (7 with matched cancer adjacent tissue), triplicate cores per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

81 Cores 27 Cases Multiple organ Adjacent triplicate cores per case special price

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

AT(*)
Malignant(IB1)
Malignant(*)
Malignant(I)
Malignant(IB)
Malignant(IIA)
Malignant(II)
Malignant(IIIA)
Malignant(IIIB)
_ma

TISSUE ARRAYS
UBD812

	1	2	3	4	5	6	7	8	9
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
G	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
H	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
I	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	_ma

UBD812

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type
A1	1	37	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant
A2	2	37	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant
A3	3	37	F	Bladder	Cancer adjacent bladder tissue	*	*	*	AT
A4	4	33	M	Bladder	High grade urothelial carcinoma with degenerate	*	T3N1M0	IIIA	Malignant
A5	5	33	M	Bladder	High grade urothelial carcinoma with degenerate	*	T3N1M0	IIIA	Malignant
A6	6	33	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT
A7	7	73	M	Bladder	High grade urothelial carcinoma (interstitial)	*	T3aN0M0	IIIA	Malignant
A8	8	73	M	Bladder	High grade urothelial carcinoma (interstitial)	*	T3aN0M0	IIIA	Malignant
A9	9	73	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT
B1	10	53	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant
B2	11	53	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant
B3	12	53	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT
B4	13	71	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant
B5	14	71	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant
B6	15	71	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT
B7	16	51	M	Bladder	Squamous cell carcinoma	2	T2bN2M0	IIIB	Malignant
B8	17	51	M	Bladder	Squamous cell carcinoma	2	T2bN2M0	IIIB	Malignant
B9	18	51	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT
C1	19	72	M	Bladder	Squamous cell carcinoma	2--3	T3bN0M0	IIIA	Malignant
C2	20	72	M	Bladder	Squamous cell carcinoma	2--3	T3bN0M0	IIIA	Malignant
C3	21	72	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT
C4	22	52	M	Bladder	Squamous cell carcinoma	3	T3N0M0	IIIA	Malignant
C5	23	52	M	Bladder	Squamous cell carcinoma	3	T3N0M0	IIIA	Malignant
C6	24	52	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT
C7	25	60	M	Bladder	Small cell carcinoma	*	T2N1M0	IIIA	Malignant
C8	26	60	M	Bladder	Small cell carcinoma	*	T2N1M0	IIIA	Malignant
C9	27	60	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT
D1	28	50	F	Bladder	Small cell carcinoma	*	T2N1M0	IIIA	Malignant
D2	29	50	F	Bladder	Small cell carcinoma	*	T2N1M0	IIIA	Malignant
D3	30	50	F	Bladder	Cancer adjacent bladder tissue	*	*	*	AT
D4	31	72	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant
D5	32	72	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant
D6	33	72	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant
D7	34	45	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant
D8	35	45	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant
D9	36	45	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant
E1	37	59	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant
E2	38	59	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant
E3	39	59	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant
E4	40	61	M	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant
E5	41	61	M	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant
E6	42	61	M	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant
E7	43	57	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant
E8	44	57	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant
E9	45	57	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant
F1	46	37	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
F2	47	37	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
F3	48	37	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
F4	49	42	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
F5	50	42	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
F6	51	42	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
F7	52	48	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
F8	53	48	F	Cervix	Squamous cell carcinoma with degenerate	2	T1b1N0M0	IB1	Malignant
F9	54	48	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
G1	55	40	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
G2	56	40	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
G3	57	40	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
G4	58	42	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
G5	59	42	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
G6	60	42	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
G7	61	48	F	Cervix	Adenosquamous carcinoma	2--3	*	*	Malignant
G8	62	48	F	Cervix	Adenosquamous carcinoma	2--3	*	*	Malignant
G9	63	48	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
H1	64	56	F	Cervix	Squamous cell carcinoma	2--3	T1b1N0M0	IB1	Malignant
H2	65	56	F	Cervix	Squamous cell carcinoma	2--3	T1b1N0M0	IB1	Malignant
H3	66	56	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
H4	67	46	F	Cervix	Squamous cell carcinoma	2	T1bN0M0	IB	Malignant
H5	68	46	F	Cervix	Squamous cell carcinoma	2	T1bN0M0	IB	Malignant
H6	69	46	F	Cervix	Squamous cell carcinoma	2	T1bN0M0	IB	Malignant
H7	70	44	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
H8	71	44	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
H9	72	44	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
I1	73	39	F	Cervix	Squamous cell carcinoma	2	T1N0M0	I	Malignant
I2	74	39	F	Cervix	Squamous cell carcinoma	2	T1N0M0	I	Malignant
I3	75	39	F	Cervix	Squamous cell carcinoma	2	T1N0M0	I	Malignant
I4	76	24	F	Cervix	Squamous cell carcinoma	2	T2aN0M0	IIA	Malignant
I5	77	24	F	Cervix	Squamous cell carcinoma	2	T2aN0M0	IIA	Malignant
I6	78	24	F	Cervix	Squamous cell carcinoma	2	T2aN0M0	IIA	Malignant
I7	79	60	F	Cervix	Squamous cell carcinoma	3	T1N0M0	I	Malignant
I8	80	60	F	Cervix	Squamous cell carcinoma	3	T1N0M0	I	Malignant
I9	81	60	F	Cervix	Squamous cell carcinoma	3	T1N0M0	I	Malignant
_marker_

Find overlapping cases with this tissue array:

UBD812

File Format: .xlsx

Release Date: 2025-01-17 16:12:36
Download

	1	2	3	4	5	6	7	8	9
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
G	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
H	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
I	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	_ma

	1	2	3	4	5	6	7	8	9
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
G	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
H	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
I	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	_ma

	1	2	3	4	5	6	7	8	9
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
G	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
H	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
I	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	_ma